Monday, December 21, 2009

Tea and coffee drinkers have a lower risk of developing type 2 diabetes

Australian researchers conducted a systematic review and meta-analysis that pooled data from more than 30 studies of the association between tea and coffee consumption and the risk of developing type 2 diabet. About a million of participants were involved.

They found that "high intake of coffee, decaffeinated coffee, and/or tea is associated with a reduction in the risk of new-onset type 2 diabetes" and the compound magnesium and antioxidants in tea and coffee may be involved.

Critics said the studies lacked sufficient data on the effects of these beverages or their components on measures of hyperglycaemia and insulin sensitivity, therefore the mechanisms involved is still unknown. It may not be possible to generalise these findings to other populations because only a small number of particpants were non-white.

Further research into the effect of these beverages on diabetes is warranted, but it is advised that people should not increase their tea or coffee consumption based on these findings.

Source: Huxley R, Man Ying Lee C, Barzi F, et al. "Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus". Arch Intern Med 2009; 169: 2053-2063

25 techniques to improve trainees' bedside skills

"Stanford 25" is a list of 25 fundamental physical examination techniques and their diagnostic benefits developed by Stanford Medical School to teach the interns to improve their skills at the bedside. It is published in the Christmas issue of the BMJ.


Abraham Verghese, professor of medicine at Stanford, wrote in the editorial, that the bedside skills of trainees in the US are declining as a result of the over-use of modern diagnostic tests. He argued that physical examination along with the taking of a good history are necessary and important in the diagnosis of clinical signs because many of them such as rebound tenderness, lid lag, tremor etc cannot be detected by an imaging test. He said that the Stanford 25 also gives "junior faculty members a repertoire of skills to teach when they are at the bedside."

Editorial : "In Praise of the Physical Examination", Abraham Verghese, Ralph Horwitz. BMJ 2009;339:b5448

Junior doctors to be tested for prescribing skills

A study commissioned by the GMC into the causes and prevalence of prescribing errors by Foundation Year doctors found that 8.9% of the prescriptions issued by doctors had errors, some of which could harm patients.

124,260 prescriptions were checked by pharmacists in 19 hospital trusts in north-west England and 11,077 errors were found. The errors included omitting drugs, wrong doses, patients’ allergies not taking into account, illegible handwriting or ambiguous orders.

When the hospital doctors were interviewed about their mistakes, some admitted they relied heavily on pharmacists and nurses as “safety net” to help catch the errors. It was found that junior doctors were ill prepared in medical school where they filled out only a few prescription forms a year, but have to complete dozens of prescriptions a day when they start as junior doctors.

The chairman of British Pharmacological Society (BPS) Prescribing Committee, Professor Simon Maxwell, said that the evidence indicated that there are serious medication errors and “such an error rate would not be acceptable”. He believed that focus on training in prescribing can improve the standards and is calling on the doctors to take the National Prescribing Assessment before they are qualified.

Sources :

GMC Press Release on 03 Dec 2009


BPS press briefing on 14 December 2009
A Blueprint for safer prescribing: BPS expresses concern about poor prescribing and calls for greater collaboration in solving the problem

Tuesday, December 15, 2009

CT scans may raise cancer risk

The hazards of radiation from CT scans was highlighted by some articles published in this week's Archives of Internal Medicine.


One study found that the number of CT scans has increased dramatically in recent years in the US putting patients at the risk of developing radiation-induced cancer. They estimated that the CT scans performed in 2007 will eventually cause 29,000 cancers and 15,000 death.


Another study found that radiation doses from common diagnostic CT scans are much higher than we previously thought and the amount of radiation varies wildly and much greater than is considered acceptable. Based on their findings, they estimated that at the age of 40, 1 in 270 women who get CT scan of the heart will develop cancer and 1 in 600 men. 1 in 8,100 women who get scans of the head and 1 in 11,080 men.


In an accompanying editorial, the author asked are such risks justified and concluded that "to avoid unnecessarily increasing cancer incidence in future years, every clinician must carefully assess the expected benefits of each CT scan and fully inform his or her patients of the known risks of radiation". Greater standardization across institutions is also needed.


Source: ( both f/t via Athens )
"Radiation Dose Associated With Common Computed Tomography Examinations and the Associated Lifetime Attributable Risk of Cancer" Arch Intern Med. 2009;169(22):2078-2086


"Cancer Risks and Radiation Exposure From Computed Tomographic Scans: How Can We Be Sure That the Benefits Outweigh the Risks?" Arch Intern Med 2009;169:2049-2050.

Thursday, December 10, 2009

The truth about Tamiflu

This week, the BMJ published a series of articles online about an update of an earlier review on oseltamivir’s efficacy in preventing complications from seasonal influenza. What makes it interesting is that in addition to the review itself, the journal also published an article that documents how the reviewers reached its current conclusion that has undermined previous findings for oseltamivir’s prevention of complications from influenza.

The story began
With the spread of the influenza A/H1N1 pandemic that began in April 2009, the use of antiviral drug has increased dramatically, the UK National Institute of Health Research commissioned an update of the Cochrane review of neuraminidase inhibitors such as Oseltamivir ( also known as Tamiflu) in healthy adults.

The Cochrane group that reviewed the efficacy of the antiflu drug in 2005, concluded at the time that oseltamivir was effective in reducing complications of flu among healthy adults. The review was criticised by a Japanese paediatrician, K Hayashi, who questioned the validity and reliability of the findings because one of the papers the review was based on was a meta-analysis of 10 trials of oseltamivir, all of which were funded by Roche, the drug manufacturer, only 2 were published in peer-reviewed journals while the remaining 8 were unpublished or published as abstract only. Hayashi challenged them to “appraise the 8 trials rigidly”.

The review team contacted the authors of the study and Roche with an attempt to verify the data but they said Roche failed to make the data available in the public domain. Eventually the team had to exclude the 8 trials in the new review, based on 20 trials, they found that there was little evidence that Tamiflu has effects on preventing complications like pneumonia and it can cut the length of illness by around a day. They call on governments to set up studies to monitor the drugs for safety.

Some critics say the new finding is not very new, it is generally known the evidence for prevention of flu complications is weak, many clinicians do not recommend the drug for healthy adults. However, others said in severely ill patients with flu-like symptoms, evidence shows that it offers some benefits.

The editor of BMJ said “Government around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge”. The new review casts doubt not only in how safe and effective Tamiflu is but also how drugs are regulated and approved.

In the UK, the British government has stockpiled tens of millions of Tamiflu doses and the drug is given to healthy people with flu via a national swine flu hotline.

Source:
"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis". BMJ 2009;339:b5106

Editorial : "Why don’t we have all the evidence on oseltamivir"? BMJ 2009;339:b5351

Applying for specialty training: top tips

A specialty trainee who was twice successful with specialty training applications, gives some advice to this year’s applicants based on her experience and those of colleagues.

Her advice, published in the BMJ Careers, includes :

- Establish your goal and the bottom line
- Organise your form - think in advance about how you will answer questions, sort out the certificates and job details, submit the application much ahead of the deadline etc.
- Prepare your portfolio
- Gather supporting documents
- Keep perspective

Source :"Applying for specialty training: top tips" BMJ Careers, 25 Nov 2009

Wednesday, December 09, 2009

Transplanting kidneys with renal masses

According to the December issue of BJU International, surgeons at the University of Maryland have transplanted 5 kidneys that have been affected by a renal mass, 3 were cancerous. So far, 1 of the recipients has died in an accident, the remaining 4 have survived between 9 and 41 months without develoing cancer.


The head of the team, Dr Michael Phelan, said both patients and the donors were aware of the cancer in the donor kidneys and the risks including recurrence of the cancer. Before the transplanting into the recipients, the surgeons removed all visible traces of the tumours. Such approach is "controversial and considered high risk" said Dr Phelan, but "The current study provides evidence to suggest that kidneys from donors with renal masses offer a minor, yet feasible, solution to the current organ shortage" and "can be transplanted into recipients with limited life-expectancy on haemodialysis after careful removal of the renal masses".


Source : "Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy" BJU International, December 2009, Volume 104, Number 11 (f/t via Athens)

Tuesday, December 08, 2009

Low-level laser therapy in neck pain

Australian researchers did a meta-analysis to assess the efficacy of low-level laser therapy (LLLT) in neck pain. LLLT is a non-invasive treatment by applying low-intensity laser beam to sites of pain. The study was published in The Lancet.

Researchers pooled data from 16 RCTs involving 820 patients with chronic neck pain comparing the efficacy of LLLT using wavelength vs placebo or active control. The authors reported that although the mechanism was unknown, LLLT was found effective in short and medium-term pain relief with moderate benefits. They also said that adverse effects from this treatment were minimal.

In an accompanying editorial, the author said that "this evidence is more solid than that for many current interventions" and "LLLT is an option worthy of consideration for management of nonspecific neck pain."


Critics warned that all 16 trials had relatively small sample sizes from 20 to 90 subjects, so the risk of bias could not be ruled out. Furthermore, many of the trials did not provide data on the side effects nor withdrawls and drop-outs that would affect the trial outcome.

Source :
Chow R, et al "Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials" Lancet 2009; DOI: 10.1016/S0140-6736(09)61522-1. (f/t via Athens)



Editorial: Guzman J "Neck pain and low-level laser: Does it work and how?" Lancet 2009; DOI: 10.1016/S0140-6736(09)61837-7. ( f/t via Athens)

Monday, December 07, 2009

Risk of blood clots after surgery is higher and lasts longer than thought

Studies have shown that the risk of developing blood clot after major surgery is high but a new study pubished in BMJ Online First on 4 December found that this risk is higher and continues for up to 3 months after surgery.

The research was a large prospective study that tracked 947,454 women, average age 56, who were diagnosed with venous thromboembolism through the NHS breast screening programme between 1996 and 2001. The reserachers checked hospital admission and death records, followed for an average of 6.2 years and compared the risk of blood clots for those who did not have surgery with those who did have surgery.

The researchers found that within 6 weeks post operation, women who had day case surgery were 10 times more likely to have blood clots than those who had no surgery. The risk for those who had surgery in the hospital were nearly 70 times higher. At 7 to 12 weeks after surgery, the risk of blood clots was 6 times higher for the day case surgery group than the no surgery group and 20 times higher for the inpatient surgery group.

They also calculated different risks for different surgery and found that the incidence of blood clots in the 12 weeks after surgey :
  • 1 in 45 had developed blood clots after hip or knee replacement;
  • 1 in 85 after cancer surgery;
  • 1 in 815 after day surgery;
  • 1 in 6,200 women who did not have surgery
The researchers warn that the risk of developing blood clot after surgery is higher and lasts for longer than previously thought and suggest that doctors should extend the time that preventive measures such as blood thinning drugs or wearing stockings are used.

Critics say that despite the lack of data on how many of the participants were taking preventive measures, this study is important because it broadens our understanding to current evidence of the risk of potential fatal blood clot after surgery and the findings may have implications for prolonged prophylaxis after surgery.

Source:
Editorial : Cohen TA. Prevention of postoperative venous thromboembolism. BMJ 2009; 339: b4477 (f/t via Athens)
Sweetland S, Green J, Liu B. et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583 ( f/t via Athens)

Thursday, December 03, 2009

Specialty training for doctors in England

Postgraduate medical training in the UK is changing, if you are considering postgraduate specialty training and seeking information on application to specialty training in England and related topics, the following documentations may help you get started with the process.


Information on the process and timetable for medical specialty training recruitment in 2010 is regularly updated on the Medical Specialty Training (England) website.

You can start by reading this BMJ article “Recruitment to medical specialty training (England) 2010” as a quick guide to the application process.

The followings aim to give F2 doctors an overview of the recruitment and application process :

Getting started

Planning your cv

Completing an application form

Preparing for the interview

Assessment centres

Preparing your portfolio

e-portfolios

Also useful :

Advise to doctors on making the most of an e-portfolio - BMJ article

Improving your chances of getting the dream job – BMJ Careers series Aug 2008

More than an interview to land the job - BMJ article Aug 2005

Writing CVs and handling job interviews - BMJ article Jun 2004